Author

T. Chatterjee

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Adhikari· 1 shared A. K. Das· 1 shared A. Sayqal· 1 shared B. Moffatt· 1 shared D. Mitra· 1 shared F. Myers· 1 shared G. Marwaha· 1 shared H. Alessa· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Adhikari

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer

J. Jacob, L. E. Francisco, T. Chatterjee, Z. Liang, S. Subramanian, Q. J. Liu, J. H. Rowe, K. S. Carmon

This study develops an antibody-drug conjugate targeting GPR56 and shows it is effective against colorectal cancer models.

bioRxiv · Aug 11, 2022Cancer Biology

A Robust, Low-Cost Instrument for Real-time Colorimetric Isothermal Nucleic Acid Amplification

F. Myers, B. Moffatt, R. El Khaja, T. Chatterjee, G. Marwaha, M. McGee, D. Mitra

The paper describes the development of a low-cost instrument for real-time colorimetric isothermal nucleic acid amplification assays, demonstrating its performance and applications.

bioRxiv · Aug 18, 2021Bioengineering

Redox Nanomedicine Cures Chronic Kidney Disease (CKD) by Mitochondrial Reconditioning

A. Adhikari, S. Mondal, T. Chatterjee, M. Das, P. Biswas, S. Darbar, H. Alessa, A. Sayqal, S. A. Ahmed, A. K. Das, M. Bhattacharyya, S. K. Pal

This study demonstrates that a redox nanomedicine, C-Mn3O4 NPs, treats CKD by restoring mitochondrial function and redox balance in animal models.

bioRxiv · Mar 14, 2021Pharmacology & Toxicology